Literature DB >> 17950497

Novel N-(phosphonomethyl) glycine derivatives: Design, characterization and biological activity.

Emilia D Naydenova1, Petar T Todorov, Margarita N Topashka-Ancheva, Georgi Ts Momekov, Tsvetelina Z Yordanova, Spiro M Konstantinov, Kolio D Troev.   

Abstract

A series of Calpha,alpha-disubstituted cyclic derivatives of N-(phosphonomethyl) glycine have been synthesized and characterized. They exhibited moderate clastogenicity, low antiproliferative activity on mice bone marrow cells and well expressed cytotoxicity against human tumor cell lines. The 8- and 12-membered cyclic analogs proved superior to the remaining compounds and were found to trigger apoptotic cell death in DOHH-2 cells. The latter compound caused 50% inhibition of the viability of hemobastose-derived cell lines at concentrations ranging from 20 to 67 microM.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17950497     DOI: 10.1016/j.ejmech.2007.08.010

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  3 in total

1.  Synthesis, cytotoxicity, DNA binding and apoptosis of rhein-phosphonate derivatives as antitumor agents.

Authors:  Man-Yi Ye; Gui-Yang Yao; Jing-Chen Wei; Ying-Ming Pan; Zhi-Xin Liao; Heng-Shan Wang
Journal:  Int J Mol Sci       Date:  2013-04-29       Impact factor: 5.923

2.  (R)-Methyl {[(2-carb-oxy-bicyclo-[2.2.2]octan-1-yl)-ammonio]-methyl}-phos-phon-ate dichloro-methane 0.25-solvate.

Authors:  Petar Todorov; Monique Calmes; Boris L Shivachev; Rosica P Nikolova
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2011-07-30

3.  Synthesis and Characterization of a Minophosphonate Containing Chitosan Polymer Derivatives: Investigations of Cytotoxic Activity and in Silico Study of SARS-CoV-19.

Authors:  Ponnusamy Packialakshmi; Perumal Gobinath; Daoud Ali; Saud Alarifi; Norah Salem Alsaiari; Akbar Idhayadhulla; Radhakrishnan Surendrakumar
Journal:  Polymers (Basel)       Date:  2021-03-26       Impact factor: 4.329

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.